Changes of Liver Function Tests Among COVID-19 Vaccinated People at IBMCHR
Islami Bank Medical College Journal · 31.07.2026 · 21 (2) · 10-18
DOI: 10.70945/ibmcj.v21i02.0175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Islami Bank Medical College Journal, online erschienen am 31.07.2026. Verfasst von Mehajabin Tusquin Khan und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Corona Virus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), prompted rapid global vaccine development and distribution. Emerging case reports have raised concern regarding hepatic adverse effects following COVID-19 vaccination, making systematic biochemical evaluation of liver function tests (LFTs) among vaccinated individuals is a matter of public health importance.
Objective
To evaluate the alterations of liver function tests among individuals who received COVID-19 vaccines at different centres in Rajshahi, Bangladesh.
Methods
A cross-sectional descriptive study was conducted at the Department of Biochemistry, Islami Bank Medical College Hospital (IBMCHR), between January 2023 to July 2023. A total of 147 vaccinated individuals (from 179 respondents with a COVID-19 vaccination history, recruited out of 325 screened) were enrolled. Data were collected by using structured questionnaire. Biochemical analysis comprised serum bilirubin (mg/dL), SGPT/ALT (U/L), and ALP (U/L), interpreted using the institutional IBMCHR laboratory reference ranges. Data were analysed in Statistical Package for Social Sciences (SPSS) version 26.0 using mean ± SD, the one-sample t-test, the chi-square test, and Pearson’s correlation, with significance level was set at p < 0.05.
Results
The mean age was 29.6 ± 16.0 years (range 8–80 years), with male predominance (102, 69.4%). Booster (third-dose) recipients constituted the largest group (71, 48.3%). Mean serum bilirubin was 2.38 ± 3.13 mg/dL, with elevation above the upper reference limit in 64 participants (43.5%; p < 0.001). Mean SGPT/ALT was 702.1 ± 1291.2 U/L, with 110 participants (74.8%) exceeding the upper reference limit (p < 0.001). Mean ALP was 161.5 ± 119.4 U/L, with elevation in 56 participants (38.1%; p = 0.012). Jaundice was the most prevalent clinical feature (55, 37.4%), followed by abdominal pain (34, 23.1%) and fever (32, 21.8%).
Conclusion
COVID-19 vaccination was associated with statistically significant elevations in hepatic biochemical parameters, most notably SGPT/ALT. Routine LFT monitoring following vaccination merits incorporation into post-immunisation surveillance protocols, particularly in resource-constrained settings.
Zitieren
APA
Khan, M. T., Sultana, P., Rahman, M. I., Rahman, T. S., & Chowdhury, N. F. (2026). Changes of Liver Function Tests Among COVID-19 Vaccinated People at IBMCHR. Islami Bank Medical College Journal, 21(2), 10-18. https://doi.org/10.70945/ibmcj.v21i02.0175
Vancouver
Khan MT, Sultana P, Rahman MI, Rahman TS, Chowdhury NF. Changes of Liver Function Tests Among COVID-19 Vaccinated People at IBMCHR. Islami Bank Medical College Journal. 2026;21(2):10-18. doi:10.70945/ibmcj.v21i02.0175
BibTeX
@article{Khan2026,
author = {Khan, Mehajabin Tusquin and Sultana, Parveen and Rahman, Md Intekhab and Rahman, Tanzila Subrina and Chowdhury, Nahid Farzana},
title = {Changes of Liver Function Tests Among COVID-19 Vaccinated People at IBMCHR},
journal = {Islami Bank Medical College Journal},
year = {2026},
volume = {21},
number = {2},
pages = {10--18},
doi = {10.70945/ibmcj.v21i02.0175}
}
EUVIMED